Radiation-Induced Brain Necrosis among patients with Nasopharyngeal Cancer Treated with Proton vs Photon Radiotherapy

Authors:

Abstract
Background: Radiation-induced brain necrosis (RIBN) is a late complication of radiotherapy (RT). Whether proton therapy reduces this risk relative to photon remains unclear in nasopharyngeal cancer (NPC).Methods: We retrospectively reviewed consecutive adults with NPC who received definitive chemoradiotherapy with photon intensity-modulated radiotherapy (IMRT) or proton RT between June 2013 and March 2025 and ≥6 months of follow-up. Cumulative incidence of brain necrosis (BN) was estimated treating death without BN as a competing event (Gray test); cause-specific Cox regression identified associated factors; overall survival (OS) was compared by log-rank test.Results: Of 256 patients, 79 (30.9%) received proton and 177 (69.1%) IMRT; median follow-up was 43 and 87 months, respectively. BN developed in 5/79 (6.3%) proton and 9/177 (5.1%) photon (P = .7674). The 2- and 5-year cumulative incidence of any-grade RIBN was 6.2% and 9.7% for proton versus 1.8% and 5.2% for photon (Gray P = .2342); for grade ≥2 RIBN, 4.7% and 4.7% versus 1.2% and 2.5% (Gray P = .3132). After adjustment for RT modality, age, and T stage, T4 disease remained independently associated with RIBN (adjusted HR, 7.39; 95% CI, 1.57–34.72; P = .0113), whereas proton therapy was not (adjusted HR, 1.77; 95% CI, 0.56–5.59; P = .3292). OS did not differ (5-year, 90.0% proton vs 80.7% photon; log-rank P = .1573).Conclusions: Proton therapy was not associated with a lower risk of RIBN than photon in NPC. Advanced T stage was the primary predictor, whereas survival and toxicity outcomes were similar between modalities.